GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (NAS:MREO) » Definitions » 5-Year Yield-on-Cost %

Mereo BioPharma Group (Mereo BioPharma Group) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Mereo BioPharma Group 5-Year Yield-on-Cost %?

Mereo BioPharma Group's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Mereo BioPharma Group's 5-Year Yield-on-Cost % or its related term are showing as below:



MREO's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.825
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Mereo BioPharma Group's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Mereo BioPharma Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mereo BioPharma Group's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's 5-Year Yield-on-Cost % falls into.



Mereo BioPharma Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Mereo BioPharma Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Mereo BioPharma Group  (NAS:MREO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Mereo BioPharma Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mereo BioPharma Group (Mereo BioPharma Group) Business Description

Traded in Other Exchanges
Address
One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Mereo BioPharma Group (Mereo BioPharma Group) Headlines

From GuruFocus